Related Experiment Video

Updated: May 18, 2026

Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells
06:09

Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells

Published on: June 7, 2019

Oncogenic NRAS signaling differentially regulates survival and proliferation in melanoma

Lawrence N Kwong1, James C Costello, Huiyun Liu

  • 1Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA.

Nature Medicine
|September 18, 2012
PubMed

Insights

Targeting NRAS-mutant melanoma requires novel strategies. Combining MEK and CDK4 inhibitors synergistically enhances therapeutic efficacy by mimicking RAS inhibition.

Area of Science:

  • Oncology
  • Molecular Biology
  • Systems Biology

Background:

  • BRAF inhibitors have transformed melanoma treatment, but NRAS-mutant melanoma lacks effective therapies.
  • Direct inhibition of RAS proto-oncogene has proven challenging.
  • Systems biology approaches are explored to identify synergistic drug combinations for NRAS-mutant melanoma.

Purpose of the Study:

  • To identify synergistic drug combinations that can effectively inhibit NRAS-mutant melanoma.
  • To investigate the differential effects of MEK inhibition versus complete NRAS extinction.
  • To develop a novel therapeutic framework for NRAS-mutant melanomas.

Main Methods:

  • Utilized an inducible mouse model of NRAS-mutant melanoma.
  • Performed pharmacological inhibition of mitogen-activated protein kinase kinase (MEK).
  • Employed network modeling to identify key signaling drivers.
  • Investigated combined inhibition of MEK and cyclin-dependent kinase 4 (CDK4).

Main Results:

  • MEK inhibition induced apoptosis but not cell-cycle arrest in NRAS-mutant melanoma.
  • Complete NRAS extinction triggered both apoptosis and cell-cycle arrest.
  • Network modeling identified CDK4 as a critical factor in the differential phenotype.
  • Combined MEK and CDK4 inhibition demonstrated significant synergistic therapeutic efficacy in vivo.

Conclusions:

  • A gradient model of oncogenic NRAS signaling explains the observed phenotypes.
  • Gated signaling leads to the decoupling of downstream biological effects.
  • Combined MEK and CDK4 inhibition offers a promising therapeutic strategy for NRAS-mutant melanomas.
  • This study provides a new framework for identifying co-targeting strategies in melanoma.

More Related Videos

Ex Vivo Culture of Circulating Tumor Cells in the Cerebral Spinal Fluid from Melanoma Patients to Study Melanoma-Associated Leptomeningeal Disease06:25

Ex Vivo Culture of Circulating Tumor Cells in the Cerebral Spinal Fluid from Melanoma Patients to Study Melanoma-Associated Leptomeningeal Disease

Published on: March 29, 2024

A 3D Organotypic Melanoma Spheroid Skin Model08:49

A 3D Organotypic Melanoma Spheroid Skin Model

Published on: May 18, 2018

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...